EQRx (EQRX) News Today → The system that called 2023’s top 7 stocks is at it again… (From WealthPress) (Ad) Free EQRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisEarningsHeadlinesOwnershipShort InterestSocial MediaStock AnalysisEarningsHeadlinesOwnershipShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRevolution Medicines, Inc. (NASDAQ:RVMD) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 28 at 12:47 PMRevolution Medicines, Inc.: Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progressfinanznachrichten.de - February 27 at 10:43 AMRevolution Medicines Inc (RVMD) Reports Earnings: R&D Investments Surge Amidst Clinical Progressuk.finance.yahoo.com - February 26 at 6:27 PMAbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcriptmsn.com - February 21 at 12:37 AMGubra AS GUBRAmorningstar.com - February 1 at 11:39 PMSoftBank adds stakes in Neumora, Globalstar in Q3; stake in WeWork slashedmsn.com - November 14 at 6:48 PMRevolution Medicines, Inc.: Revolution Medicines and EQRx Stockholders Approve EQRx Acquisitionfinanznachrichten.de - November 9 at 12:18 PMRevolution Medicines, Inc.: Revolution Medicines Completes Acquisition of EQRxfinanznachrichten.de - November 9 at 12:18 PMmarketbeat.com - November 9 at 6:04 AMRevolution Medicines and EQRx stockholders approves acquisitionmsn.com - November 8 at 4:17 PMRevolution Medicines, Inc.: Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progressfinanznachrichten.de - November 7 at 10:28 AMWe're Hopeful That EQRx (NASDAQ:EQRX) Will Use Its Cash Wiselyfinance.yahoo.com - November 2 at 2:22 PMCalling All EQRx, Inc. (EQRX) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Lossesbarrons.com - October 20 at 7:19 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMNB, NEWR, EQRX, SCUbenzinga.com - October 8 at 3:50 PMEQRX Shareholder Investigation: Robbins LLP Reminds Shareholders it is Investigating EQRx, Inc. on behalf of Shareholdersbenzinga.com - September 27 at 2:18 PMApplied BioMath, LLC Hosts 6th Annual Quantitative Systems Pharmacology Summitfinance.yahoo.com - September 26 at 5:40 PMProfund Advisors LLC Acquires New Position in EQRx, Inc. (NASDAQ:EQRX)marketbeat.com - September 5 at 6:51 AMConnor Clark & Lunn Investment Management Ltd. Has $845,000 Stock Holdings in EQRx, Inc. (NASDAQ:EQRX)marketbeat.com - August 24 at 5:20 AMSG Americas Securities LLC Has $134,000 Stake in EQRx, Inc. (NASDAQ:EQRX)marketbeat.com - August 14 at 4:27 AMEQRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of EQRx, Inc. - EQRXbusinesswire.com - August 3 at 12:16 AMRevolution Medicines will buy EQRx in an all-stock transactionmsn.com - August 1 at 4:56 PMEQRx sells to another Alexis Borisy biotech after multiple pivotsbizjournals.com - August 1 at 4:56 PMRevolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capitalfinance.yahoo.com - August 1 at 4:56 PMEQRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of EQRx, Inc. Is Fair to Shareholdersbusinesswire.com - August 1 at 10:10 AMmarketbeat.com - August 1 at 6:58 AMShort Interest in EQRx, Inc. (NASDAQ:EQRX) Rises By 5.4%marketbeat.com - July 21 at 11:36 AMEQRx, Inc. (NASDAQ:EQRX) has caught the attention of institutional investors who hold a sizeable 47% stakefinance.yahoo.com - June 29 at 8:21 AMUBS Group AG Grows Stake in EQRx, Inc. (NASDAQ:EQRX)marketbeat.com - June 6 at 4:39 AMCornercap Investment Counsel Inc. Buys New Stake in EQRx, Inc. (NASDAQ:EQRX)marketbeat.com - June 2 at 8:26 AMConnor Clark & Lunn Investment Management Ltd. Takes $808,000 Position in EQRx, Inc. (NASDAQ:EQRX)marketbeat.com - June 1 at 7:00 AMCStone Breaks Up With Drugs Partner As U.S. Rollout Stallsseekingalpha.com - May 19 at 5:00 AMOppenheimer & Co. Inc. Has $37,000 Stock Position in EQRx, Inc. (NASDAQ:EQRX)marketbeat.com - May 17 at 5:29 AMThe World Has Its Way With EQRxmsn.com - May 10 at 10:12 AMQ1 2023 EQRx Inc Earnings Callfinance.yahoo.com - May 9 at 9:39 AMEQRx Announces Massive Strategic Reset, Slashes Pipeline & Workforcemarkets.businessinsider.com - May 9 at 9:39 AMEQRx, Inc. (EQRX) Q1 2023 Earnings Call Transcriptseekingalpha.com - May 8 at 10:57 PMEQRx GAAP EPS of -$0.17 misses by $0.03msn.com - May 8 at 6:37 PMEQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 8 at 6:37 PMEQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Resultsfinance.yahoo.com - May 8 at 6:37 PMHandelsbanken Fonder AB Purchases New Position in EQRx, Inc. (NASDAQ:EQRX)marketbeat.com - May 8 at 5:42 AMEarnings Outlook For EQRxmsn.com - May 5 at 4:12 PMEQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023finance.yahoo.com - April 27 at 8:15 AMEQRx, Inc. (EQRX) Shareholder Investigation: Robbins LLP is Investigating EQRX, Inc. on behalf of Shareholderstechnews.tmcnet.com - April 21 at 10:48 PMVBI Vaccines (VBIV) Down 53% on Initiating Restructuring Plansmsn.com - April 5 at 2:12 PMEQRx Chief Financial Officer Jami Rubin Resigns >EQRXmarketwatch.com - March 13 at 5:49 PMAlphabet Inc. Takes $235.39 Million Position in EQRx, Inc. (NASDAQ:EQRX)marketbeat.com - March 13 at 11:36 AMCompany founded to make 'radically' cheap drugs lays off 66bizjournals.com - February 24 at 9:04 AMEQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progressfinance.yahoo.com - February 23 at 8:16 AMEQRx GAAP EPS of -$0.05 beats by $0.14msn.com - February 23 at 8:16 AMEQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progressfinance.yahoo.com - February 23 at 8:16 AM Get EQRx News Delivered to You Automatically Sign up to receive the latest news and ratings for EQRX and its competitors with MarketBeat's FREE daily newsletter. Email Address This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry EQRX Media Mentions By Week EQRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EQRX News Sentiment▼0.000.43▲Average Medical News Sentiment EQRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EQRX Articles This Week▼00▲EQRX Articles Average Week Get EQRx News Delivered to You Automatically Sign up to receive the latest news and ratings for EQRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADAP News Today MIRM News Today SRRK News Today TARS News Today MNKD News Today XNCR News Today ATRC News Today ABCL News Today GMTX News Today COLL News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EQRX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EQRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
